New Market Report: Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011

Feb. 13, 2011 - PRLog -- Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, "Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011"" provides data on the Zollinger-Ellison Syndrome clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Zollinger-Ellison Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
* Clinical trial (complete and in progress) data by phase, trial status and trial success rate
* Review of key discontinued trials (suspended, withdrawn and terminated)
* Overview of the enrollment pattern by phase for the past decade
* Number of clinical trials segmented by key drugs
* Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
* Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others


Reasons to buy

* Understand the dynamics of a particular indication as a whole
* Examine the performance of the trials in terms of their status, recruitment, success rates and others
* Obtain discontinued trial information for trials across the globe
* Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/114041_zollingerellison_syndro...


Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Zollinger-Ellison Syndrome
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by Phase
Clinical Trials by Trial Status
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2011*
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2011*
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2011*
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2011*

List of Figures
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
Zollinger-Ellison Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Zollinger-Ellison Syndrome Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011*
GlobalData Methodology

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.